These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

55 related items for PubMed ID: 21446836

  • 1. Pharmacokinetics of antofloxacin hydrochloride in healthy male subjects after multiple intravenous dose administration.
    Wang J, Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Liang J, Zhang M, Li T.
    Xenobiotica; 2011 Jul; 41(7):561-6. PubMed ID: 21446836
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK, Cheng G, Tang J, Song J, Peng WX.
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers.
    Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Zhang M, Li T.
    Biopharm Drug Dispos; 2008 Apr; 29(3):167-72. PubMed ID: 18240275
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M, Almeida L, Falcão A, Soares E, Maia J, Nunes T, Soares-da-Silva P.
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and tolerability of etamicastat following single and repeated administration in elderly versus young healthy male subjects: an open-label, single-center, parallel-group study.
    Nunes T, Rocha JF, Vaz-da-Silva M, Falcão A, Almeida L, Soares-da-Silva P.
    Clin Ther; 2011 Jun; 33(6):776-91. PubMed ID: 21704242
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics of antofloxacin in renally impaired rats.
    Pang XY, Liu L, Zhang DM, Wang GJ, Xie L, Liu XD.
    J Pharm Pharmacol; 2008 May; 60(5):667-70. PubMed ID: 18416945
    [Abstract] [Full Text] [Related]

  • 13. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE, Golden JA, McIver M, Zurlinden E.
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of a once-daily extended-release formulation of pramipexole in healthy male volunteers: three studies.
    Jenner P, Könen-Bergmann M, Schepers C, Haertter S.
    Clin Ther; 2009 Nov; 31(11):2698-711. PubMed ID: 20110012
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
    Tsaganos T, Kouki P, Digenis P, Giamarellou H, Giamarellos-Bourboulis EJ, Kanellakopoulou K.
    Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
    [Abstract] [Full Text] [Related]

  • 16. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 17. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D, Tack K, Flor S.
    Int J Clin Pharmacol Res; 1991 May; 11(5):203-9. PubMed ID: 1814841
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH, Shin KH, Kim J, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [Abstract] [Full Text] [Related]

  • 20. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
    Vollmer T, Blight AR, Henney HR.
    Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.